@article{f6f66ed4394749b7a75eb6c04f290393,
title = "Corrigendum to “Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [177Lu]Lu-PSMA-617 in the Phase 3 VISION Trial” [Eur. Urol. 86 (2024) 552–562, (S0302283824025600), (10.1016/j.eururo.2024.08.021)]",
abstract = "The authors regret a minor data error in the reporting of best radiographic responses in Supplementary Table 5 in the Supplementary Material. The percentage of patients with an evaluable response who had progressive disease (PD) in the 'Increase' subgroup for best overall PSA decline from baseline in the 177Lu-PSMA-617 arm should be 31% not 40%. The number of patients with PD (n = 22) and the denominator (n = 71) remain correct. The data in the Table should therefore read as {\textquoteleft}22 (31){\textquoteright} not {\textquoteleft}22 (40){\textquoteright}. The authors also note that the rows in this Table are slightly misaligned vertically but are presented in the correct order.[Figure presented] The authors would like to apologise for any inconvenience caused.",
author = "Armstrong, {Andrew J.} and Oliver Sartor and {de Bono}, Johann and Kim Chi and Karim Fizazi and Krause, {Bernd J.} and Ken Herrmann and Kambiz Rahbar and Tagawa, {Scott T.} and Fred Saad and Beer, {Tomasz M.} and Jiwen Wu and Osvaldo Mirante and Morris, {Michael J.}",
note = "Publisher Copyright: {\textcopyright} 2025 The Author(s)",
year = "2025",
month = jan,
day = "1",
doi = "10.1016/j.eururo.2025.03.008",
language = "English",
journal = "European Urology",
issn = "0302-2838",
}